Extensive mutations of lankacidin synthase genes were carried out to analyze the modular-iterative mixed polyketide biosynthesis of lankacidin. Three ketoreductase domains (lkcC-KR, lkcF-KR1, and lkcF-KR2) were inactivated by in-frame deletion and site-directed mutagenesis of their active sites. The mutants ceased or diminished lankacidin production, indicating that the three KR domains are functional in lankacidin biosynthesis. However, all of the KR mutants failed to accumulate the expected unreduced metabolites. Mutational analysis of two tandemly aligned acyl carrier protein domains (lkcC-ACP1 and lkcC-ACP2) revealed that either ACP is sufficient for lankacidin production. Disruption and complementation experiments on three unique genes/domain (lkcD for acyltransferase, lkcB for dehydratase, and lkcC-MT for a C-methyltransferase domain) suggested that their gene products function iteratively during lankacidin biosynthesis.
Extensive mutations of lankacidin synthase genes were carried out to analyze the modular-iterative mixed polyketide biosynthesis of lankacidin. Three ketoreductase domains (lkcC-KR, lkcF-KR1, and lkcF-KR2) were inactivated by in-frame deletion and site-directed mutagenesis of their active sites. The mutants ceased or diminished lankacidin production, indicating that the three KR domains are functional in lankacidin biosynthesis. However, all of the KR mutants failed to accumulate the expected unreduced metabolites. Mutational analysis of two tandemly aligned acyl carrier protein domains (lkcC-ACP1 and lkcC-ACP2) revealed that either ACP is sufficient for lankacidin production. Disruption and complementation experiments on three unique genes/domain (lkcD for acyltransferase, lkcB for dehydratase, and lkcC-MT for a C-methyltransferase domain) suggested that their gene products function iteratively during lankacidin biosynthesis.
Key words: antibiotic; polyketide synthase; Streptomyces rochei; biosynthesis Lankacidin ( Fig. 1 ), 1) a unique 17-membered carbocyclic antibiotic, is produced by Streptomyces rochei strain 7434AN4, which carries three linear plasmids, pSLA2-L, -M, and -S.
2) The complete nucleotide sequencing of the largest plasmid pSLA2-L (210,614 bp) together with gene disruption experiments have revealed that the lankacidin synthase (lkc) gene cluster (lkcA-lkcO) is located on pSLA2-L. 3, 4) Lankacidin belongs to a group of reduced polyketides including macrolides and polyene macrolides, which are usually biosynthesized by modular type-I polyketide synthases (PKSs). Typical modular PKSs contain several ketosynthase (KS) and ketoreductase (KR) domains, whose numbers exactly coincide with the numbers of chain extension and reduction reactions; that is, a colinear relationship is observed between domains and reactions. [5] [6] [7] [8] However, the lkc cluster contains five KS domains although eight condensation reactions are necessary for the synthesis of the lankacidin skeleton. Hence, it was speculated that one (or some) of the five lkc-PKS modules may function iteratively instead of modularly.
To analyze the modular-iterative mixed biosynthesis of lankacidin, we have carried out heterologous expression and gene fusion experiments.
9) The introduction of the whole lkc cluster into Streptomyces lividans resulted in the production of lankacidinol A (Fig. 1) . Thus the lkcA-lkcO genes are sufficient for synthesis of the lankacidin skeleton, but not for the final steps, including the oxidation of the lactate moiety and the hydrolysis of the C-7 acetoxy group. These final steps might be done by enzymes coded on the S. rochei chromosome. On the other hand, the gene fusant of two PKS genes, lkcF and lkcG, produced lankacidin at a comparable level to the parent strain 51252. This result suggested a modular function of the LkcF and LkcG proteins, because gene fusion of two modular PKSs did not affect antibiotic production, 10) while that including an iterative PKS greatly reduced it.
11) All of these results led us to propose a hypothesis, that LkcC is used 4 times and the remaining three PKS proteins (LkcA, LkcF, and LkcG) are used modularly to accomplish eight condensation cycles in lankacidin biosynthesis (Fig. 1) .
This hypothesis exactly agrees with the chemical structure of lankacidin. The nonribosomal peptide synthetase (NRPS)/PKS hybrid protein LkcA recognizes glycine as a starter and condenses it with malonyl coenzyme A (CoA). Then LkcC extends the polyketide chain 4 times, from C-14 to C-7. Finally, two modules in LkcF and one in LkcG catalyze three rounds of chain extension and modification reactions to create the lankacidin skeleton. Three KR domains (lkcC-KR, lkcF-KR1, and lkcF-KR2) are arranged in the cluster to catalyze seven rounds of reduction of -keto groups during polyketide assembly.
Similar iterative use of modular PKSs has been proposed for stigmatellin biosynthesis in Stigmatella aurantiaca, 12) borrelidin in Streptomyces parvulus, 11) aureothin in Streptomyces thioluteus, 13) and neocarzilin in Streptomyces carzinostaticus.
14) It was suggested that either StiI or StiJ is used twice for stigmatellin biosynthesis, BorA5 3 times for borrelidin, AurA twice for aureothin, and Orf6 twice for neocarzilin, but no metabolites confirming their iterative use have been isolated.
To isolate key metabolites supporting the modulariterative polyketide biosynthesis of lankacidin, we carried out extensive mutations of the lkc-PKS genes in this study. The target genes for mutations were three KR domains (lkcC-KR, lkcF-KR1, and lkcF-KR2) and two tandemly aligned acyl carrier protein (ACP) domains (lkcC-ACP1 and lkcC-ACP2). In addition, three unique genes/domain in the cluster, lkcD for acyltransferase (AT), lkcB for dehydratase (DH), and lkcC-MT for a C-methyltransferase (MT) domain, were mutated to analyze their iterative function.
Materials and Methods
Bacterial strains and culture conditions. All the strains used in this study are listed in Table 1 . Designed oligonucleotides are listed in Table 2 . The plasmids constructed or used in this study are listed in Supplemental Table S1 , and the construction schemes of gene disruptants are shown in Supplemental Figs. S1-S15 (see Biosci. Biotechnol. Biochem. Web site). Site-directed mutations were introduced by the Altered Sites II in vitro Mutagenesis System (Promega, Madison, WI). S. rochei strain 51252, which carries only pSLA2-L, 2) was used as the parent strain. DNA manipulations for E. coli 15) and Streptomyces 16) were performed according to the standard protocols. YEME liquid medium 16) was used in the preparation of protoplasts. Protoplasts were regenerated on R1M solid medium. 17) Thiostrepton (10 mg/ml) was used in the selection of plasmid-integrated Streptomyces strains. E. coli strain XL1-Blue was used in routine cloning and construction of targeting plasmids. Ampicillin (100 mg/ml), apramycin (50 mg/ml), or tetracycline (10 mg/ml) was added to Luria-Bertani (LB) medium when necessary. DIG DNA labeling and detection kit (Roche Diagnostics GmbH, Mannheim, Germany) was used for Southern hybridization analysis.
Construction of targeting plasmids.
In-frame deletion of lkcC-KR: A 2.9-kb SalI fragment (nt 28,208-31,118 of pSLA2-L) from cosmid B10 3) was cloned into pUC19 to give pFSU16-01. The 141-bp StuI-NruI fragment in the targeted lkcC-KR portion was eliminated by double digestion and self-ligation to give pFSU16-02. The vector part of pFSU16-02 was replaced with an E. coli-Streptomyces shuttle vector pRES18 18) to give a targeting plasmid, pFSU16-03.
In-frame deletion of lkcF-KR1: A 2.4-kb FspI-EcoRI fragment (nt 19,975-22,371) from cosmid B10 was cloned into pUC19 predigested with SmaI and EcoRI to give pFSU13-01. The 387-bp AvaI fragment in the targeted lkcF-KR1 portion was eliminated to give pFSU13-03. The vector part of pFSU13-03 was replaced by pRES18 to give a targeting plasmid, pFSU13-05.
In-frame deletion of lkcF-KR2: A 3.2-kb PstI-StuI (nt 16,621-19,851) fragment from cosmid B10 was cloned into pUC19 predigested with PstI and SmaI to give pFSU13-02. The 456-bp HincII fragment in the targeted lkcF-KR2 portion was eliminated to give pFSU13-04. The vector part of pFSU13-04 was replaced by pRES18 to give a targeting plasmid, pFSU13-06.
S362A mutation of lkcC-KR: Plasmid pFSU16-01 was digested with BamHI and HindIII, and a 2.1-kb fragment was recloned into pUC57 (Fermentas, Vilnius, Lithuania) to give pST16KR-01. The 2.1-kb BamHI-StuI fragment from pST16KR-01 was cloned into pAlter-1 (Promega) to give pST16KR-02. The lkcC-KR S362A mutation was introduced by oligonucleotide ST1008 to give a mutated plasmid, pST16KR-03. The 2.1-kb BamHI-StuI fragment from pST16KR-03 was substituted for the original fragment in pST16KR-01 to give pST16KR-04, the vector of which was replaced by pRES18 to give a targeting plasmid, pST16KR-06.
S330A mutation of lkcF-KR1: Plasmid pFSU13-01 was digested with EcoRI and PstI, and the insert was recloned into pBluescript SK(+) to give pKAR1010. The 1.4-kb EcoRI-SphI fragment from pKAR1010 was cloned into pAlter-1 to give pKAR1011. The lkcF-KR1 S330A mutation was introduced by oligonucleotide KAR-1301S01 to give a mutated plasmid, pKAR1012. The 1.4-kb EcoRI-SphI fragment from pKAR1012 was substituted for the original fragment in pKAR1010 to give pKAR1013, the vector of which was replaced by pRES18 to give a targeting plasmid, pKAR1014. S1523A mutation of lkcF-KR2: Plasmid pFSU13-02 was digested with EcoRI and PstI, and the insert was recloned into pAlter-1 to give pST13KR2-01. The lkcF-KR2 S1523A mutation was introduced by oligonucleotide ST1006 to give a mutated plasmid, pST13KR2-02. The vector part of pST13KR2-02 was replaced by pRES18 to give a targeting plasmid, pST13KR2-03.
Y343F mutation of lkcF-KR1: The lkcF-KR1 Y343F mutation was introduced into pKAR1011 by oligonucleotide KAR-1301Y01 to give a mutated plasmid, pKAR1016. The 0.31-kb AgeI-SphI fragment from pKAR1016 was substituted for the original fragment in pKAR1010 to give pKAR1018, the vector of which was replaced by pRES18 to give a targeting plasmid, pKAR1020.
Y1536F mutation of lkcF-KR2: The lkcF-KR2 Y1536F mutation was introduced into pST13KR2-01 by oligonucleotide ST1007 to give a mutated plasmid, pST13KR2-04. The vector part of pST13KR2-04 was replaced by pRES18 to give a targeting plasmid, pST13KR2-05.
S851A mutation of lkcC-ACP1: The 1.4-kb PCR fragment containing the 3 0 -portion of lkcC-ACP1 S851A was amplified using cosmid B10 as a template and primers ST1000 and ST1001. The 0.54-kb PCR fragment containing the 5 0 -portion of lkcC-ACP1 S851A was amplified using cosmid B10 and primers ST1002 and ST1003. The 1.4-kb PCR fragment was digested with EcoRI and NsiI and cloned into Litmus28i (New England Biolabs, Ipswich, MA) to give pSTACP05. The 0.54-kb PCR fragment digested with NsiI and BglII was cloned into pSTACP05 to give pSTACP06. The 1.6-kb ApaI-BglII fragment from pSTACP06 was substituted for the original fragment of pKAR1006 to give pSTACP07, the vector of which was replaced by pRES18 to give a targeting plasmid, pSTACP08.
S956A mutation of lkcC-ACP2: The 1.1-kb PCR fragment containing the 3 0 -portion of lkcC-ACP2 S956A was amplified using cosmid B10
and primers ST1000 and ST1001. The 0.85-kb PCR fragment containing the 5 0 -portion of lkcC-ACP2 S956A was amplified using cosmid B10 and primers ST1002 and ST1003. The 1.1-kb PCR product was digested with EcoRI and NsiI and cloned into Litmus28i to give pSTACP01. The 0.85-kb PCR fragment digested with NsiI and BglII was cloned into pSTACP01 to give pSTACP02. The 1.6-kb ApaI-BglII fragment from pSTACP02 was substituted for the original fragment in pKAR1006 to give pSTACP03, the vector of which was replaced by pRES18 to give a targeting plasmid, pSTACP04.
S851A-S956A double mutation of lkcC-ACP1 and lkcC-ACP2: A 315-bp BstEII fragment from pSTACP04, which carries the lkcC-ACP2 S956A mutation, was substituted for the original fragment in pSTACP08 to give a targeting plasmid, pSTACP09.
In-frame deletion of lkcC-ACP2: The 315-bp BstEII fragment was eliminated from pSTACP04, and the resulting DNA was ligated to give a targeting plasmid, pSTACP10.
Deletion of lkcD: A 2.3-kb BspEI-BglII fragment (nt 22,755-25,038) from cosmid B10 was cloned into Litmus 28i to give pSTAT01. This plasmid was digested with BglII and SalI, and recloned into pET32b(+) (Novagen, Darmstadt, Germany) to give pSTAT02. The 0.52-kb BsiWI-AgeI fragment in the middle of lkcD was eliminated from pSTAT02, and the resulting DNA was filled in and self-ligated to give pSTAT03. The 1.0-kb BglII-SalI fragment from pSTAT03 was substituted for the original fragment in pSTAT01 to give pSTAT04, the vector of which was replaced by pRES18 to give a targeting plasmid, pSTAT05.
Insertional mutation of lkcB: A 1.9-kb NotI fragment (nt 30,023-31,932) from cosmid B10 was cloned into pBluescript SK(+) to give pSTDH01. This plasmid was digested with XbaI and SacI, and the insert was recloned into pUC19 to give pSTDH02. A 1.2-kb SmaI fragment containing the kanamycin resistance gene cassette 19) was inserted into the SmaI site in the middle of lkcB to give pSTDH03. The vector part of pSTDH03 was replaced by pRES18 to give a targeting plasmid, pSTDH04.
In-frame deletion of lkcC-MT: A 3.8-kb NcoI fragment (nt 25,693-29,514) from cosmid B10 was cloned into pRSET-B (Invitrogen, Carlsbad, CA) to give pKAR1005. The 3.8-kb EcoRI-PstI insert in pKAR1005 was cloned into pUC19 to give pKAR1006. The 135-bp BamHI-BglII fragment was eliminated from pKAR1006 to give pKAR1007, the vector of which was replaced by pRES18 to give a targeting plasmid, pKAR1008.
Construction of various PKS mutants.
Targeting plasmids were transformed into S. rochei 51252 protoplasts. The plasmid-integrated strains were selected with thiostrepton (10 mg/ml), and were serially cultured in the absence of thiostrepton to facilitate the second crossover. The double-crossovered strains were identified by Southern hybridization analysis.
Analysis of metabolites. S. rochei strains were cultured at 28 C for 2 d in 500-ml Sakaguchi flasks. Cultured broth was extracted twice with ethyl acetate, and the combined organic phase was dried (Na 2 SO 4 ), filtered, and concentrated to dryness. The lankacidin production of the mutants was analyzed by high performance liquid chromatography (HPLC) and electrospray-ionization mass spectrometry (ESI-MS). The crude extract was applied on a COSMOSIL 5C18-MS-II column (4:6 Â 250 mm, Nakarai Tesque, Kyoto, Japan) and eluted with a mixture of acetonitrile-10 mM sodium phosphate buffer (pH 8.2) (3:7, v/v) at a flow rate of 1.0 ml/min. The eluate was monitored at 230 nm with a MD-2010 multiwavelength photodiode array detector (Jasco, Tokyo, Japan). Lankacidin C and lankacidinol A were detected at 8.5 min and 16.9 min, respectively. The relative yield of lankacidin C in various mutants was determined from peak intensities on a chromatogram in comparison with the parent strain, 51252. ESI-MS spectra were recorded on an ALLIANCE2690/ ZQ2000 mass spectrometer (Waters, Milford, MA).
Complementation by intact lkcD and lkcB. The lkcD gene was amplified by PCR using cosmid B10 as template and primers ORF15-1 and ORF15-3. The amplified product was digested with NdeI and BglII and cloned into pIJ8600, an E-coli-Streptomyces shuttle vector carrying a thiostrepton-inducible promoter, 20) to give plasmid pSTAT06N. This plasmid was transformed into protoplasts of the lkcD mutant STAT01. The transformant was cultured at 28 C in YM liquid medium supplemented with apramycin (20 mg/ml) for 24 h, and then thiostrepton (10 mg/ml) was added to induce expression of lkcD. After further cultivation for 2 d, the supernatant was extracted with ethyl acetate. Plasmid pIJ8600 was also transformed as a control.
The lkcB gene was amplified by PCR using cosmid B10 as template and primers ORF17-1N and ORF17-2N. The amplified product was digested with XbaI and BamHI and cloned into pIJ8600 to give plasmid pSTDH05N. Complementation of lkcB in the lkcB mutant STDH01 was carried out in a way similar to lkcD.
Results
Three ketoreductase domains, LkcC-KR, LkcF-KR1, and LkcF-KR2, were functional in lankacidin biosynthesis
In erythromycin biosynthesis, a mutant carrying an inframe deletion in the eryAIII-KR5 domain produced the expected unreduced 5-keto compound, 5,6-dideoxy-3--L-mycarosyl-5-oxoerythronolide B.
21) The lkc cluster contains three KR domains, lkcC-KR, lkcF-KR1, and lkcF-KR2. Based on our hypothesis (Fig. 1) , it was speculated that the lkcF-KR1 and lkcF-KR2 domains are involved in the reduction of the two ketone groups at C-7 and C-5 respectively. To obtain unreduced lankacidin derivatives, mutational analysis of these three KR domains was done.
First, KR mutants were constructed by in-frame deletion. The lkcC-KR mutant FS16 (ÁlkcC-KR) was constructed by deletion of a 141-bp DNA. The ÁlkcF-KR1 mutant KSFS13-1 was constructed by deletion of a 387-bp DNA, and the ÁlkcF-KR2 mutant FS13-2 by deletion of a 456-bp DNA. The detailed construction schemes of the mutants are shown in Supplemental data (see Biosci. Biotechnol. Biochem. Web site). Metabolites of these KR deletion mutants were analyzed by high performance liquid chromatography (HPLC) of their ethyl acetate extracts. The parent strain, 51252, showed two peaks, lankacidin C at 8.5 min and lankacidinol A at 14.8 min (Fig. 2-I ). On the other hand, three deletion mutants did not show these peaks (Fig. 2-II-IV) . We also searched for 5-keto and 7-keto compounds and other unreduced metabolites by TLC, HPLC, and ESI-MS based on their predicted conjugated double bonds and molecular sizes, but did not detect them in any KR deletion mutants.
It is likely that the three deletion mutants did not produce lankacidin or its derivatives due to wrong folding of the mutated proteins with a large deletion. To minimize this possibility, we next mutated the KR domains by amino acid substitution. The KR domains contain conserved lysine, serine, and tyrosine residues, which form a catalytic triad. 22) Hence, the serine and tyrosine residues were replaced with alanine and phenylalanine respectively. At the same time, a new restriction site was introduced to confirm the mutation. Consequently, an lkcC-KR S362A mutant with a BsrGI site (strain STKR04), an lkcF-KR1
S330A mutant with an Eco47III site (strain KA14), and an lkcF-KR2 S1523A mutant with an EcoRV site (strain STKR01) were obtained. The lkcC-KR S362A mutant did not produce lankacidin, while the lkcF-KR1
S330A and lkcF-KR2 S1523A mutants produced 38% and 2.2% of lankacidin C as compared with strain 51252 (Fig. 2-V-VII) . The identity of the metabolite with lankacidin C was established by ESI-MS [ðM þ NaÞ þ ¼ 482]. Another series of mutants with replacement of tyrosine by phenylalanine were also constructed: an lkcF-KR1
Y343F mutant with a PstI site (strain KA35) and an lkcF-KR2
Y1536F mutant with an EcoRI site (strain STKR02). Neither mutant produced lankacidin at all (Fig. 2-VIII and IX) . None of the five KR substitution mutants accumulated unreduced lankacidin derivatives. 
Either of the two tandemly aligned ACP domains was sufficient for lankacidin biosynthesis
The LkcC protein carries two tandemly aligned ACP domains (LkcC-ACP1 and LkcC-ACP2). Similar tandem alignments of two ACP domains have been found in several bacterial and fungal type-I PKSs, for example, albicidin PKS of Xanthomonas albilineans, 23) mupirocin PKS of Pseudomonas fluorescens, 24) and naphtopyrone and sterigmatocystin PKSs of Aspergillus nidulans. 25, 26) To determine the function of LkcC-ACP1 and LkcC-ACP2, three types of substitution mutants were constructed by site-directed mutagenesis. Since the lkcC-ACP1 and lkcC-ACP2 domains have identical nucleotide sequences, PCR amplification using a pair of a mutated ACP primer and an outside primer gave two amplified products of different size, each containing a mutation in ACP1 and ACP2. In this way, a Ser-to-Ala mutation and an NsiI site were introduced into ACP1 and ACP2. Proper combinations of two PCR products were ligated to construct targeting plasmids for mutation. Thus an lkcC-ACP1 S851A mutant (strain STACP01), an lkcC-ACP2 S956A mutant (strain STACP02), and an lkcC-ACP1
S851A . lkcC-ACP2 S956A double mutant (strain STACP03) were obtained. Both the lkcC-ACP1
S851A
and the lkcC-ACP2
S956A mutant produced 54% of lankacidin C as compared with strain 51252, while the lkcC-ACP1
S851A . lkcC-ACP2
S956A double mutant did not produce lankacidin (Fig. 3) .
We also constructed a solo ACP mutant (strain STACP04, ÁlkcC-ACP2) by eliminating a 315-bp BstEII fragment covering the ACP2 region. The ÁlkcC-ACP2 mutant produced 48% of lankacidin C as compared with strain 51252, a comparable level to the lkcC-ACP1
S851A
and lkcC-ACP2
S956A mutants (Fig. 3-VI) . However, no ring-contracted lankacidin derivatives were detected in any of the four ACP mutants.
Acyltransferase LkcD, dehydratase LkcB, and the C-methyltransferase domain LkcC-MT act iteratively
The lkc cluster contains three unique genes/domain for lankacidin biosynthesis; two discrete genes (lkcD and lkcB) for acyltransferase (AT) and dehydratase (DH), and one domain (lkcC-MT) for C-methyltransferase (MT). Since no other genes or domains with AT, DH, and MT activities are found in the cluster, their gene products might act iteratively to accomplish polyketide assembly.
The discrete AT protein, LkcD, contains a catalytic serine residue in the GHSXG motif (nt 24,295-24,281 of pSLA2-L), 27) which is conserved in all the AT proteins/ domains (Fig. 4A) . Gene inactivation of lkcD was carried out by deletion of a 0.52-kb AgeI-BsiWI fragment containing this motif. The disruptant obtained, STAT01 (ÁlkcD), completely abolished lankacidin production ( Fig. 5-II) , and this defect was complemented by the introduction of an intact lkcD gene (Fig. 5-III) .
The discrete dehydratase gene lkcB was inactivated by insertion of a kanamycin resistance gene cassette into the SmaI site in the middle of the gene. The resulting mutant, STDH01 (lkcB::kan), did not produce any lankacidin derivatives (Fig. 5-V) , and this defect was also restored by the introduction of an intact lkcB gene (Fig. 5-VI) .
Feeding experiments on labeled S-adenosyl-L-methionine (SAM) revealed that four methyl groups, at C-2, C-4, C-10, and C-16, of the lankacidin skeleton were introduced by C-methylation.
28) The unique LkcC-MT domain in the cluster contains an SAM-binding EXGXG motif (nt 28,275-28,261) characteristic of C-methyltransferases. 29) Disruption of lkcC-MT was carried out by in-frame deletion of a 135-bp BamHI-BglII fragment containing this motif. The disruptant, KA03 (ÁlkcC-MT), did not produce lankacidin (Fig. 5-VIII) , and contrary to our expectations, the mutant did not produce desmethyl lankacidin derivatives. We have not yet done complementation experiments due to the domain structure of lkcC-MT.
Discussion
In this study, we carried out extensive mutations of the lkc-PKS genes to isolate key metabolites supporting the modular-iterative mixed biosynthesis of lankacidin. Although we have not succeeded in isolating the expected lankacidin derivatives from any mutants, analysis of their metabolic abilities revealed several features of the Lkc-PKS enzymes.
Crystallographic analysis of tropinone reductase-II, a short-chain dehydrogenase/reductase (SDR) from the plant Datura stramonium, showed that the conserved serine residue stabilizes the substrate by hydrogen bonding, while the catalytic tyrosine residue has a proton-donating function to a -keto group of the substrate.
30) The KR domains in actinomycete modular PKSs showed end-to-end sequence similarities to SDRs. Hence, we mutated the serine and tyrosine residues in the lkcC-KR, lkcF-KR1, and lkcF-KR2 domains to obtain unreduced metabolites. In the case of the Ser-to-Ala substitution, the lkcF-KR1 and lkcF-KR2 mutants produced decreased levels of lankacidin (38% and 2.2% as compared to strain 51252), while the lkcC-KR mutant B A I, strain 51252 (parent); II, strain STAT01 (ÁlkcD); III, strain STAT01 harboring pSTAT06 (lkcD complement); IV, strain STAT01 harboring pIJ8600 (control); V, strain STDH01 (lkcB::kan); VI, strain STDH01 harboring pSTDH05 (lkcB complement); VII, strain STDH01 harboring pIJ8600 (control), VIII, strain KA03 (ÁlkcC-MT).
ceased lankacidin production. Thus the serine residue in the KR domains is important but not critical for the enzyme activity. It is reasonable that the Ser-to-Ala mutation of the lkcC-KR domain resulted in nonproduction of lankacidin, because LkcC might function iteratively in the early steps of biosynthesis. In contrast to the Ser-to-Ala mutation, the Tyr-to-Phe mutation of the lkcF-KR1 and lkcF-KR2 domains abolished lankacidin production, indicating that the proton-donating function of the tyrosine residue has a critical role in ketoreduction. In this study, we could not isolate any unreduced metabolites of lankacidin from any of the KR mutants. This is in contrast to typical modular polyketide biosynthesis, in which the KR mutants accumulate unreduced metabolites of erythromycin. 21, 31) Thus the Lkc-PKS enzymes might strictly recognize the structures of unidentified intermediates, including their reductive states.
All of the three mutants carrying one active LkcC-ACP domain produced about half the amount of lankacidin as compared with strain 51252, but not any ring-contracted derivatives. Thus, either ACP is sufficient for lankacidin biosynthesis, and the tandem alignment of two ACPs is not essential for iterative condensation. Accumulated examples also suggest no relationship between tandem alignment and iterative condensation. [24] [25] [26] The copy numbers of ACP genes/domains rather than their tandem alignment appears to function in overall PKS activity. 32, 33) Introduction of the tetracenomycin ACP gene on a high-copy vector into the wild-type strain of Streptomyces glaucescens caused 30-fold production of tetracenomycin D3. 32) Shen et al. analyzed the function of sextet ACP domains in the eicosapentaenoic acid (EPA) synthase of Shewanella japonica. 34) They constructed many mutants in which one to six ACP domains were inactivated. Mutants with the same number of active ACPs produced similar amounts of EPA, indicating a correlation between the number of active ACPs and the titer of EPA. Thus the tandem alignment of two ACP domains in LkcC might also increase the ACP concentration and affect the titer of lankacidin.
The acyltransferase (AT) activity in modular PKSs is integrated into each module as a domain and functions once in elongation cycles (named cis-AT).
5) Cis-AT domains contain consensus recognition sequences for malony or methylmalonyl CoA (Fig. 4A) , which gives structure diversity to polyketides. On the other hand, discrete AT genes were found first in the pksX cluster for a cryptic polyketide of Bacillus subtilis, 35) and then in the clusters for mupirocin of Pseudomonas fluorescens, 24) leinamycin of Streptomyces atroolivaceus, 36) and pederin of a bacterial symbiont of the beetle Paederus fuscipes. 37) In all these cases, only malonyl CoA was transferred in trans iteratively to other PKSs (named trans-ATs). Disruption and complementation of the discrete lkcD gene in the lkc cluster indicated that LkcD belongs to trans-ATs and that it transfers eight malonyl CoA molecules to LkcA, LkcC, LkcF, and LkcG. Reflecting these differences, three types of AT domains/proteins are grouped into different phylogenetic clusters (Fig. 4B) . Very recently, in silico analysis of the kirromycin cluster from Streptomyces collinus suggested that KirCII, one of the two trans-ATs, functions in the transfer of ethylmalony CoA. 38) The lkc cluster does not possess a dehydratase (DH) domain, instead containing a discrete DH gene, lkcB. Disruption and complementation experiments have suggested that LkcB functions in trans iteratively to generate all of the four double bonds, at C-8=C-9, C-10=C-11, C-14=C-15, and C-16=C-17. A similar lack of DH domains in type-I PKS modules was found in the biosynthetic clusters for chalcomycin in Streptomyces bikiniensis, 39) leinamycin in S. atroolivaceus, 36) and macrolactin in Bacillus amyloliquefaciens.
40) Modules 3, 5, and 7 of the leinamycin cluster do not possess a DH domain, which is required for biosynthesis. Since discrete DH genes are not present in the cluster, it is likely that the unique DH domain in module 4 functions in trans iteratively. To our knowledge, the biosynthetic gene cluster for coronafacic acid from Pseudomonas syringae 41) is the only example in which a discrete DH gene has been identified in type-I PKSs. However, in this case, the discrete DH enzyme functions on a pentanone moiety, which is formed after completion of the polyketide backbone. Thus the present study provides the first evidence that a discrete DH enzyme functions iteratively in trans in type-I polyketide biosynthesis.
Disruption of the lkcC-MT domain in this study together with previous heterologous expression of the lkc cluster in S. lividans 9) indicates that this domain iteratively introduces four methyl groups at C-2, C-4, C-10, and C-16 of the lankacidin skeleton. Heterologous expression of alt5, an iterative type-I PKS gene with a MT domain from Alternaria solani, also produced a correctly methylated product, alternapyrone, in Aspergillus oryzae. 42) Contrary to our expectations, the lkcC-MT mutant did not accumulate desmethyl lankacidin, suggesting that the Lkc-PKS modules do not process intermediates lacking methyl substituents. On the other hand, disruption of the discrete MT genes in the type-II PKS clusters for mithramycin in Streptomyces argillaceus 43) and coumermycin in Streptomyces rishiriensis 44) gave desmethyl derivatives. In both cases the MT enzymes function only once on a specific position of the intermediate. Although disruption and complementation of the discrete genes/domain, lkcD, lkcB, and lkcC-MT, suggested an iterative use of their gene products, the possibility that other enzymes are involved in the iterative reactions cannot be ruled out. However, this possibility appears extremely low, because the lankacidin skeleton was synthesized by heterologous expression of the lkc cluster in S. lividans. 9) Thus the results of this study indicate the modular-iterative mixed polyketide biosynthesis of lankacidin in a different way from that which we anticipated at first. Moreover, they suggest challenging questions as to how LkcB and LkcC-MT select the reaction sites for dehydration and C-methylation from multiple candidate sites. The lasting question how modular and iterative condensations can be distinguished by LkcA, LkcC, LkcF, and LkcG remains to be solved.
